Lysosome-activated apoptosis represents an alternative method of overcoming tumor resistance compared to traditional forms of treatment. Pulsed magnetic fields open a new avenue for controlled and targeted initiation of lysosomal permeabilization in cancer cells via mechanical actuation of magnetic nanomaterials. In this study we used a noninvasive tool; namely, a benchtop pulsed magnetic system, which enabled remote activation of apoptosis in liver cancer cells. The magnetic system we designed represents a platform that can be used in a wide range of biomedical applications. We show that liver cancer cells can be loaded with superparamagnetic iron oxide nanoparticles (SPIONs). SPIONs retained in lysosomal compartments can be effectively actuated with a high intensity (up to 8 T), short pulse width (~15 µs), pulsed magnetic field (PMF), resulting in lysosomal membrane permeabilization (LMP) in cancer cells. We revealed that SPION-loaded lysosomes undergo LMP by assessing an increase in the cytosolic activity of the lysosomal cathepsin B. The extent of cell death induced by LMP correlated with the accumulation of reactive oxygen species in cells. LMP was achieved for estimated forces of 700 pN and higher. Furthermore, we validated our approach on a three-dimensional cellular culture model to be able to mimic in vivo conditions. Overall, our results show that PMF treatment of SPION-loaded lysosomes can be utilized as a noninvasive tool to remotely induce apoptosis.

Institut Néel Grenoble INP CNRS Université Grenoble Alpes 38000 Grenoble France

Institute for Clinical and Experimental Medicine 14021 Prague Czech Republic

Institute of Experimental Medicine of the Czech Academy of Sciences 14220 Prague Czech Republic

Institute of Physics of the Czech Academy of Sciences 18221 Prague Czech Republic

J Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences 18223 Prague Czech Republic

Universidade Federal do Paraná DELT Curitiba 81531 980 Brazil

See more in PubMed

Pankhurst Q., Jones S., Dobson J. Applications of magnetic nanoparticles in biomedicine: The story so far. J. Phys. D Appl. Phys. 2016;49:501002. doi: 10.1088/0022-3727/49/50/501002. DOI

Dobson J. Remote control of cellular behaviour with magnetic nanoparticles. Nat. Nanotechnol. 2008;3:139–143. doi: 10.1038/nnano.2008.39. PubMed DOI

Gaster R.S., Hall D.A., Nielsen C.H., Osterfeld S.J., Yu H., Mach K.E., Wilson R.J., Murmann B., Liao J.C., Gambhir S.S., et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 2009;15:1327–1332. doi: 10.1038/nm.2032. PubMed DOI PMC

Haun J.B., Castro C.M., Wang R., Peterson V.M., Marinelli B.S., Lee H., Weissleder R. Micro-NMR for rapid molecular analysis of human tumor samples. Sci. Transl. Med. 2011;3:71ra16. doi: 10.1126/scitranslmed.3002048. PubMed DOI PMC

Kircher M.F., Gambhir S.S., Grimm J. Noninvasive cell-tracking methods. Nat. Rev. Clin. Oncol. 2011;8:677–688. doi: 10.1038/nrclinonc.2011.141. PubMed DOI

Kircher M.F., Mahmood U., King R.S., Weissleder R., Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003;63:8122–8125. PubMed

Kozissnik B., Bohorquez A.C., Dobson J., Rinaldi C. Magnetic fluid hyperthermia: Advances, challenges, and opportunity. Int. J. Hyperth. 2013;29:706–714. doi: 10.3109/02656736.2013.837200. PubMed DOI

Guo M., Que C., Wang C., Liu X., Yan H., Liu K. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials. 2011;32:185–194. doi: 10.1016/j.biomaterials.2010.09.077. PubMed DOI

Golovin Y.I., Gribanovsky S.L., Golovin D.Y., Klyachko N.L., Majouga A.G., Master A.M., Sokolsky M., Kabanov A.V. Towards nanomedicines of the future: Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields. J. Control. Release. 2015;219:43–60. doi: 10.1016/j.jconrel.2015.09.038. PubMed DOI PMC

Tseng P., Judy J.W., Di Carlo D. Magnetic nanoparticle-mediated massively parallel mechanical modulation of single-cell behavior. Nat. Methods. 2012;9:1113–1119. doi: 10.1038/nmeth.2210. PubMed DOI PMC

Colombo M., Carregal-Romero S., Casula M.F., Gutierrez L., Morales M.P., Bohm I.B., Heverhagen J.T., Prosperi D., Parak W.J. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 2012;41:4306–4334. doi: 10.1039/c2cs15337h. PubMed DOI

Kim D.H., Rozhkova E.A., Ulasov I.V., Bader S.D., Rajh T., Lesniak M.S., Novosad V. Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nat. Mater. 2010;9:165–171. doi: 10.1038/nmat2591. PubMed DOI PMC

Master A.M., Williams P.N., Pothayee N., Pothayee N., Zhang R., Vishwasrao H.M., Golovin Y.I., Riffle J.S., Sokolsky M., Kabanov A.V. Remote actuation of magnetic nanoparticles for cancer cell selective treatment through cytoskeletal disruption. Sci. Rep. 2016;6:33560. doi: 10.1038/srep33560. PubMed DOI PMC

Leulmi S., Chauchet X., Morcrette M., Ortiz G., Joisten H., Sabon P., Livache T., Hou Y.X., Carriere M., Lequien S., et al. Triggering the apoptosis of targeted human renal cancer cells by the vibration of anisotropic magnetic particles attached to the cell membrane. Nanoscale. 2015;7:15904–15914. doi: 10.1039/C5NR03518J. PubMed DOI

Domenech M., Marrero-Berrios I., Torres-Lugo M., Rinaldi C. Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano. 2013;7:5091–5101. doi: 10.1021/nn4007048. PubMed DOI

Zhang E., Kircher M.F., Koch M., Eliasson L., Goldberg S.N., Renstrom E. Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation. ACS Nano. 2014;8:3192–3201. doi: 10.1021/nn406302j. PubMed DOI PMC

Wong W., Gan W.L., Liu N., Lew W.S. Magneto-actuated cell apoptosis by biaxial pulsed magnetic field. Sci. Rep. 2017;7:10919. doi: 10.1038/s41598-017-11279-w. PubMed DOI PMC

Wong W., Gan W.L., Teo Y.K., Lew W.S. Interplay of cell death signaling pathways mediated by alternating magnetic field gradient. Cell Death Discov. 2018;4:49. doi: 10.1038/s41420-018-0052-7. PubMed DOI PMC

Shin Y.C., Song S.J., Hong S.W., Jeong S.J., Chrzanowski W., Lee J.C., Han D.W. Multifaceted biomedical applications of functional graphene nanomaterials to coated substrates, patterned arrays and hybrid scaffolds. Nanomaterials. 2017;7:369. doi: 10.3390/nano7110369. PubMed DOI PMC

Elbez R., McNaughton B.H., Patel L., Pienta K.J., Kopelman R. Nanoparticle induced cell magneto-rotation: Monitoring morphology, stress and drug sensitivity of a suspended single cancer cell. PLoS ONE. 2011;6:e28475. doi: 10.1371/journal.pone.0028475. PubMed DOI PMC

Hapuarachchige S., Kato Y., Ngen E.J., Smith B., Delannoy M., Artemov D. Non-temperature induced effects of magnetized iron oxide nanoparticles in alternating magnetic field in cancer cells. PLoS ONE. 2016;11:e0156294. doi: 10.1371/journal.pone.0156294. PubMed DOI PMC

Uzhytchak M., Lynnyk A., Zablotskii V., Dempsey N.M., Dias A.L., Bonfim M., Lunova M., Jirsa M., Kubinova S., Lunov O., et al. The use of pulsed magnetic fields to increase the uptake of iron oxide nanoparticles by living cells. Appl. Phys. Lett. 2017;111:243703. doi: 10.1063/1.5007797. DOI

Lunov O., Syrovets T., Rocker C., Tron K., Nienhaus G.U., Rasche V., Mailander V., Landfester K., Simmet T. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials. 2010;31:9015–9022. doi: 10.1016/j.biomaterials.2010.08.003. PubMed DOI

Lunov O., Syrovets T., Buchele B., Jiang X., Rocker C., Tron K., Nienhaus G.U., Walther P., Mailander V., Landfester K., et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials. 2010;31:5063–5071. doi: 10.1016/j.biomaterials.2010.03.023. PubMed DOI

Tukmachev D., Lunov O., Zablotskii V., Dejneka A., Babic M., Sykova E., Kubinova S. An effective strategy of magnetic stem cell delivery for spinal cord injury therapy. Nanoscale. 2015;7:3954–3958. doi: 10.1039/C4NR05791K. PubMed DOI

Lunov O., Zablotskii V., Syrovets T., Rocker C., Tron K., Nienhaus G.U., Simmet T. Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials. 2011;32:547–555. doi: 10.1016/j.biomaterials.2010.08.111. PubMed DOI

Zablotskii V., Lunov O., Dejneka A., Jastrabik L., Polyakova T., Syrovets T., Simmet T. Nanomechanics of magnetically driven cellular endocytosis. Appl. Phys. Lett. 2011;99:183701. doi: 10.1063/1.3656020. DOI

Qin J., Laurent S., Jo Y.S., Roch A., Mikhaylova M., Bhujwalla Z.M., Muller R.N., Muhammed M. A high-performance magnetic resonance Imaging T-2 contrast agent. Adv. Mater. 2007;19:2411. doi: 10.1002/adma.200790066. DOI

Wang Y.X.J., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 2001;11:2319–2331. doi: 10.1007/s003300100908. PubMed DOI

Allkemper T., Bremer C., Matuszewski L., Ebert W., Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: Effect of size and dose on vascular contrast enhancement in rabbits. Radiology. 2002;223:432–438. doi: 10.1148/radiol.2232010241. PubMed DOI

Wilhelm S., Tavares A.J., Dai Q., Ohta S., Audet J., Dvorak H.F., Chan W.C.W. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 2016;1:16014. doi: 10.1038/natrevmats.2016.14. DOI

Yu M., Zheng J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano. 2015;9:6655–6674. doi: 10.1021/acsnano.5b01320. PubMed DOI PMC

Letters A.P. The dose makes the poison. Nat. Nanotechnol. 2011;6:329. doi: 10.1038/nnano.2011.87. PubMed DOI

Oberdorster G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 2010;267:89–105. doi: 10.1111/j.1365-2796.2009.02187.x. PubMed DOI

Feng Q., Liu Y., Huang J., Chen K., Huang J., Xiao K. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep. 2018;8:2082. doi: 10.1038/s41598-018-19628-z. PubMed DOI PMC

Hamm B., Staks T., Taupitz M., Maibauer R., Speidel A., Huppertz A., Frenzel T., Lawaczeck R., Wolf K.J., Lange L. Contrast-enhanced MR imaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxide. J. Magn. Reson. Imaging. 1994;4:659–668. doi: 10.1002/jmri.1880040508. PubMed DOI

Kemp S.J., Ferguson R.M., Khandhar A.P., Krishnan K.M. Monodisperse magnetite nanoparticles with nearly ideal saturation magnetization. RSC Adv. 2016;6:77452–77464. doi: 10.1039/C6RA12072E. DOI

Zablotskii V., Polyakova T., Lunov O., Dejneka A. How a high-gradient magnetic field could affect cell life. Sci. Rep. 2016;6:37407. doi: 10.1038/srep37407. PubMed DOI PMC

Zhu W., von dem Bussche A., Yi X., Qiu Y., Wang Z., Weston P., Hurt R.H., Kane A.B., Gao H. Nanomechanical mechanism for lipid bilayer damage induced by carbon nanotubes confined in intracellular vesicles. Proc. Natl. Acad. Sci. USA. 2016;113:12374–12379. doi: 10.1073/pnas.1605030113. PubMed DOI PMC

Kalwarczyk T., Ziebacz N., Bielejewska A., Zaboklicka E., Koynov K., Szymanski J., Wilk A., Patkowski A., Gapinski J., Butt H.J., et al. Comparative analysis of viscosity of complex liquids and cytoplasm of mammalian cells at the nanoscale. Nano Lett. 2011;11:2157–2163. doi: 10.1021/nl2008218. PubMed DOI

Kast D.J., Dominguez R. The cytoskeleton-autophagy connection. Curr. Biol. 2017;27:R318–R326. doi: 10.1016/j.cub.2017.02.061. PubMed DOI PMC

Pu J., Guardia C.M., Keren-Kaplan T., Bonifacino J.S. Mechanisms and functions of lysosome positioning. J. Cell Sci. 2016;129:4329–4339. doi: 10.1242/jcs.196287. PubMed DOI PMC

Schwake M., Schroder B., Saftig P. Lysosomal membrane proteins and their central role in physiology. Traffic. 2013;14:739–748. doi: 10.1111/tra.12056. PubMed DOI

Gonzalez-Rodriguez D., Guillou L., Cornat F., Lafaurie-Janvore J., Babataheri A., de Langre E., Barakat A.I., Husson J. Mechanical criterion for the rupture of a cell membrane under compression. Biophys. J. 2016;111:2711–2721. doi: 10.1016/j.bpj.2016.11.001. PubMed DOI PMC

Pierzynska-Mach A., Janowski P.A., Dobrucki J.W. Evaluation of acridine orange, lysotracker red, and quinacrine as fluorescent probes for long-term tracking of acidic vesicles. Cytom. Part A. 2014;85:729–737. doi: 10.1002/cyto.a.22495. PubMed DOI

Kirkegaard T., Roth A.G., Petersen N.H.T., Mahalka A.K., Olsen O.D., Moilanen I., Zylicz A., Knudsen J., Sandhoff K., Arenz C., et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature. 2010;463:549–553. doi: 10.1038/nature08710. PubMed DOI

Petersen N.H.T., Olsen O.D., Groth-Pedersen L., Ellegaard A.M., Bilgin M., Redmer S., Ostenfeld M.S., Ulanet D., Dovmark T.H., Lonborg A., et al. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell. 2013;24:379–393. doi: 10.1016/j.ccr.2013.08.003. PubMed DOI

Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434–6451. doi: 10.1038/onc.2008.310. PubMed DOI

Settembre C., Fraldi A., Medina D.L., Ballabio A. Signals from the lysosome: A control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 2013;14:283–296. doi: 10.1038/nrm3565. PubMed DOI PMC

Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., Ojcius D.M., Jaattela M., Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 2003;197:1323–1334. doi: 10.1084/jem.20021952. PubMed DOI PMC

Erdal H., Berndtsson M., Castro J., Brunk U., Shoshan M.C., Linder S. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc. Natl. Acad. Sci. USA. 2005;102:192–197. doi: 10.1073/pnas.0408592102. PubMed DOI PMC

Lynnyk A., Lunova M., Jirsa M., Egorova D., Kulikov A., Kubinova S., Lunov O., Dejneka A. Manipulating the mitochondria activity in human hepatic cell line Huh7 by low-power laser irradiation. Biomed. Opt. Express. 2018;9:1283–1300. doi: 10.1364/BOE.9.001283. PubMed DOI PMC

Smolkova B., Lunova M., Lynnyk A., Uzhytchak M., Churpita O., Jirsa M., Kubinova S., Lunov O., Dejneka A. Non-thermal plasma, as a new physicochemical source, to induce redox imbalance and subsequent cell death in liver cancer cell lines. Cell. Physiol. Biochem. 2019;52:119–140. doi: 10.33594/000000009. PubMed DOI

Lunova M., Prokhorov A., Jirsa M., Hof M., Olzynska A., Jurkiewicz P., Kubinova S., Lunov O., Dejneka A. Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell lines. Sci. Rep. 2017;7:16049. doi: 10.1038/s41598-017-16447-6. PubMed DOI PMC

Krysko O., de Ridder L., Cornelissen M. Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis. 2004;9:495–500. doi: 10.1023/B:APPT.0000031452.75162.75. PubMed DOI

Galluzzi L., Vitale I., Aaronson S.A., Abrams J.M., Adam D., Agostinis P., Alnemri E.S., Altucci L., Amelio I., Andrews D.W., et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486–541. doi: 10.1038/s41418-017-0012-4. PubMed DOI PMC

Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19:107–120. doi: 10.1038/cdd.2011.96. PubMed DOI PMC

Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009;16:3–11. doi: 10.1038/cdd.2008.150. PubMed DOI PMC

Lunov O., Zablotskii V., Churpita O., Lunova M., Jirsa M., Dejneka A., Kubinova S. Chemically different non-thermal plasmas target distinct cell death pathways. Sci. Rep. 2017;7:600. doi: 10.1038/s41598-017-00689-5. PubMed DOI PMC

Kang M.A., So E.Y., Simons A.L., Spitz D.R., Ouchi T. DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death Dis. 2012;3:e249. doi: 10.1038/cddis.2011.134. PubMed DOI PMC

Lunov O., Zablotskii V., Churpita O., Jager A., Polivka L., Sykova E., Dejneka A., Kubinova S. The interplay between biological and physical scenarios of bacterial death induced by non-thermal plasma. Biomaterials. 2016;82:71–83. doi: 10.1016/j.biomaterials.2015.12.027. PubMed DOI

Lunova M., Smolkova B., Uzhytchak M., Janouskova K.Z., Jirsa M., Egorova D., Kulikov A., Kubinova S., Dejneka A., Lunov O. Light-induced modulation of the mitochondrial respiratory chain activity: Possibilities and limitations. Cell Mol. Life Sci. 2019 doi: 10.1007/s00018-019-03321-z. PubMed DOI PMC

Langhans S.A. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front. Pharmacol. 2018;9:6. doi: 10.3389/fphar.2018.00006. PubMed DOI PMC

Xu X., Farach-Carson M.C., Jia X. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol. Adv. 2014;32:1256–1268. doi: 10.1016/j.biotechadv.2014.07.009. PubMed DOI PMC

Tomasini M.D., Rinaldi C., Tomassone M.S. Molecular dynamics simulations of rupture in lipid bilayers. Exp. Biol. Med. 2010;235:181–188. doi: 10.1258/ebm.2009.009187. PubMed DOI

Hare J.I., Lammers T., Ashford M.B., Puri S., Storm G., Barry S.T. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Adv. Drug Deliv. Rev. 2017;108:25–38. doi: 10.1016/j.addr.2016.04.025. PubMed DOI

Hua S., de Matos M.B.C., Metselaar J.M., Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: Pathways for translational development and commercialization. Front. Pharmacol. 2018;9:790. doi: 10.3389/fphar.2018.00790. PubMed DOI PMC

Rosenblum D., Joshi N., Tao W., Karp J.M., Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 2018;9:1410. doi: 10.1038/s41467-018-03705-y. PubMed DOI PMC

Barenholz Y. Doxil(R)--the first FDA-approved nano-drug: Lessons learned. J. Control. Release. 2012;160:117–134. doi: 10.1016/j.jconrel.2012.03.020. PubMed DOI

Zhang Y.N., Poon W., Tavares A.J., McGilvray I.D., Chan W.C.W. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. J. Control. Release. 2016;240:332–348. doi: 10.1016/j.jconrel.2016.01.020. PubMed DOI

Piao S., Amaravadi R.K. Targeting the lysosome in cancer. Ann. N. Y. Acad. Sci. 2016;1371:45–54. doi: 10.1111/nyas.12953. PubMed DOI PMC

Serrano-Puebla A., Boya P. Lysosomal membrane permeabilization as a cell death mechanism in cancer cells. Biochem. Soc. Trans. 2018;46:207–215. doi: 10.1042/BST20170130. PubMed DOI

Joris F., De Backer L., Van de Vyver T., Bastiancich C., De Smedt S.C., Raemdonck K. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells. J. Control. Release. 2018;269:266–276. doi: 10.1016/j.jconrel.2017.11.019. PubMed DOI

Lunova M., Smolkova B., Lynnyk A., Uzhytchak M., Jirsa M., Kubinova S., Dejneka A., Lunov O. Targeting the mTOR signaling pathway utilizing nanoparticles: A critical overview. Cancers. 2019;11:82. doi: 10.3390/cancers11010082. PubMed DOI PMC

Fehrenbacher N., Jäättelä M. Lysosomes as targets for cancer therapy. Cancer Res. 2005;65:2993–2995. doi: 10.1158/0008-5472.CAN-05-0476. PubMed DOI

Wang F., Gomez-Sintes R., Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19:918–931. doi: 10.1111/tra.12613. PubMed DOI

Ni Z.H., Wang B., Dai X.F., Ding W., Yang T., Li X.Z., Lewin S., Xu L., Lian J.Q., He F.T. HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway. Free Radic. Biol. Med. 2014;70:194–203. doi: 10.1016/j.freeradbiomed.2014.02.012. PubMed DOI

Guo L., Dial S., Shi L.M., Branham W., Liu J., Fang J.L., Green B., Deng H., Kaput J., Ning B.T. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab. Dispos. 2011;39:528–538. doi: 10.1124/dmd.110.035873. PubMed DOI PMC

Pattingre S., Levine B. Bcl-2 inhibition of autophagy: A new route to cancer? Cancer Res. 2006;66:2885–2888. doi: 10.1158/0008-5472.CAN-05-4412. PubMed DOI

Lindqvist L.M., Heinlein M., Huang D.C.S., Vaux D.L. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc. Natl. Acad. Sci. USA. 2014;111:8512–8517. doi: 10.1073/pnas.1406425111. PubMed DOI PMC

Ashkenazi A., Fairbrother W.J., Leverson J.D., Souers A.J. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat. Rev. Drug Discov. 2017;16:273–284. doi: 10.1038/nrd.2016.253. PubMed DOI

Lessene G., Czabotar P.E., Colman P.M. BCL-2 family antagonists for cancer therapy. Nat. Rev. Drug Discov. 2008;7:989–1000. doi: 10.1038/nrd2658. PubMed DOI

Johansson A.C., Appelqvist H., Nilsson C., Kagedal K., Roberg K., Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 2010;15:527–540. doi: 10.1007/s10495-009-0452-5. PubMed DOI PMC

Mrschtik M., Ryan K.M. Lysosomal proteins in cell death and autophagy. FEBS J. 2015;282:1858–1870. doi: 10.1111/febs.13253. PubMed DOI

Lunov O., Zablotskii V., Churpita O., Chanova E., Sykova E., Dejneka A., Kubinova S. Cell death induced by ozone and various non-thermal plasmas: Therapeutic perspectives and limitations. Sci. Rep. 2014;4:7129. doi: 10.1038/srep07129. PubMed DOI PMC

Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele G.D., Jr., Chen L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA. 1991;88:3671–3675. doi: 10.1073/pnas.88.9.3671. PubMed DOI PMC

Zuliani T., Duval R., Jayat C., Schnebert S., Andre P., Dumas M., Ratinaud M.H. Sensitive and reliable JC-1 and TOTO-3 double staining to assess mitochondrial transmembrane potential and plasma membrane integrity: Interest for cell death investigations. Cytom. A. 2003;54:100–108. doi: 10.1002/cyto.a.10059. PubMed DOI

Foty R. A simple hanging drop cell culture protocol for generation of 3D spheroids. J. Vis. Exp. 2011 doi: 10.3791/2720. PubMed DOI PMC

Petrenko Y., Sykova E., Kubinova S. The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids. Stem Cell Res. Ther. 2017;8:94. doi: 10.1186/s13287-017-0558-6. PubMed DOI PMC

Hamilton N. Quantification and its applications in fluorescent microscopy imaging. Traffic. 2009;10:951–961. doi: 10.1111/j.1600-0854.2009.00938.x. PubMed DOI

Dell R.B., Holleran S., Ramakrishnan R. Sample size determination. ILAR J. 2002;43:207–213. doi: 10.1093/ilar.43.4.207. PubMed DOI PMC

Iron oxide nanoparticles trigger endoplasmic reticulum damage in steatotic hepatic cells

The interactions between DNA nanostructures and cells: A critical overview from a cell biology perspective

Protein Corona Inhibits Endosomal Escape of Functionalized DNA Nanostructures in Living Cells

Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis

Iron Oxide Nanoparticle-Induced Autophagic Flux Is Regulated by Interplay between p53-mTOR Axis and Bcl-2 Signaling in Hepatic Cells